Literature DB >> 24800704

Teletriage for provision of dermatologic care: a pilot program in the Department of Veterans Affairs.

Jenna Lester, Martin A Weinstock.   

Abstract

BACKGROUND: The scarcity of dermatologists has prompted the creation of innovative methods for delivering dermatologic care.
METHODS: Teletriage is a method used in teledermatology to efficiently assess skin complaints in patients who do not have prompt access to conventional dermatologic care. Their primary care clinicians are provided with management recommendations, reassured that the lesion of concern is benign, or recommended to send their patient for a face-to-face dermatology visit. The Providence VA Medical Center conducted a pilot program testing the utility of teletriage for patients with skin complaints from June 2011 to August 2011.
RESULTS: The pilot program revealed that with the teletriage protocol, face-to-face visits were reduced by 38%. This program suggests that teletriage could be a useful tool for providing efficient dermatologic care, and has led to broader implementation.
CONCLUSION: Teletriage is a potentially useful approach for efficiently addressing specific dermatologic complaints and improving access to care for those complaints.

Entities:  

Mesh:

Year:  2014        PMID: 24800704     DOI: 10.2310/7750.2013.13086

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  3 in total

1.  Teledermatology Education: Current Use of Teledermatology in US Residency Programs.

Authors:  Karolyn A Wanat; Sabrina Newman; Kristina M Finney; Carrie L Kovarik; Ivy Lee
Journal:  J Grad Med Educ       Date:  2016-05

2.  Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review.

Authors:  Edward Hadeler; Howard Gitlow; Keyvan Nouri
Journal:  Arch Dermatol Res       Date:  2020-07-28       Impact factor: 3.017

3.  Contribution of a synchronic teleneurology program to decrease the patient number waiting for a first consultation and their waiting time in Chile.

Authors:  Freddy Constanzo; Paula Aracena-Sherck; Juan Pablo Hidalgo; Lorena Peña; Mery Marrugo; Jonathan Gonzalez; Gerardo Vergara; Cristóbal Alvarado
Journal:  BMC Med Inform Decis Mak       Date:  2020-02-05       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.